Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares EORTC 62012: doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced soft tissue sarcoma, Malignant peripheral nerve sheath tumour (MPNST), Undifferentiated pleomorphic sarcoma (UPS), Soft tissue sarcoma of the extremity (localised and advanced) and the tag subtype-page.
Shares EORTC 62012: doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced soft tissue sarcoma, Liposarcoma, Undifferentiated pleomorphic sarcoma (UPS), Leiomyosarcoma and the tag subtype-page.
Shares Trabectedin, Pazopanib, Liposarcoma, Undifferentiated pleomorphic sarcoma (UPS) and the tag subtype-page.
Shares Trabectedin, Leiomyosarcoma, Soft tissue sarcoma of the extremity (localised and advanced), Doxorubicin and the tag subtype-page.
Shares Liposarcoma, Leiomyosarcoma, IMRT / IGRT (modern external beam), Sarcomas (soft tissue, bone, GIST) and the tag subtype-page.
Shares Soft tissue sarcoma of the extremity (localised and advanced), Ifosfamide, Ewing sarcoma, Doxorubicin and the tag subtype-page.
Shares Alveolar soft part sarcoma, Epithelioid sarcoma, Doxorubicin, Sarcomas (soft tissue, bone, GIST) and the tag subtype-page.
Shares Pazopanib, Doxorubicin, IMRT / IGRT (modern external beam), Sarcomas (soft tissue, bone, GIST) and the tag subtype-page.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.